Compare Dar Al Dawa Development & Investment Co. Ltd. with Similar Stocks
Dashboard
1
With a growth in Net Profit of 214.24%, the company declared Very Positive results in Dec 25
- The company has declared positive results for the last 2 consecutive quarters
- INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
- RAW MATERIAL COST(Y) Fallen by -9.31% (YoY)
- NET SALES(Q) Highest at JOD 25.53 MM
2
With ROE of 0.00%, it has a attractive valuation with a 0.00 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-0.83%
0%
-0.83%
6 Months
6.25%
0%
6.25%
1 Year
7.27%
0%
7.27%
2 Years
-3.55%
0%
-3.55%
3 Years
13.33%
0%
13.33%
4 Years
15.53%
0%
15.53%
5 Years
-11.19%
0%
-11.19%
Dar Al Dawa Development & Investment Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
8.94%
EBIT Growth (5y)
27.83%
EBIT to Interest (avg)
2.02
Debt to EBITDA (avg)
2.90
Net Debt to Equity (avg)
0.66
Sales to Capital Employed (avg)
0.81
Tax Ratio
9.75%
Dividend Payout Ratio
17.43%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.76%
ROE (avg)
9.51%
Valuation key factors
Factor
Value
P/E Ratio
9
Industry P/E
Price to Book Value
NA
EV to EBIT
4.05
EV to EBITDA
3.39
EV to Capital Employed
NA
EV to Sales
0.75
PEG Ratio
0.32
Dividend Yield
NA
ROCE (Latest)
NA
ROE (Latest)
NA
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ
Dec'25
Sep'25
Change(%)
Net Sales
25.50
18.70
36.36%
Operating Profit (PBDIT) excl Other Income
6.20
2.30
169.57%
Interest
1.00
1.00
Exceptional Items
-0.10
0.00
Consolidate Net Profit
3.70
1.20
208.33%
Operating Profit Margin (Excl OI)
196.00%
70.90%
12.51%
USD in Million.
Net Sales
QoQ Growth in quarter ended Dec 2025 is 36.36% vs -2.09% in Sep 2025
Consolidated Net Profit
QoQ Growth in quarter ended Dec 2025 is 208.33% vs 0.00% in Sep 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
81.60
79.70
2.38%
Operating Profit (PBDIT) excl Other Income
13.40
11.40
17.54%
Interest
3.90
3.90
Exceptional Items
-0.20
-0.10
-100.00%
Consolidate Net Profit
6.60
3.70
78.38%
Operating Profit Margin (Excl OI)
113.30%
93.60%
1.97%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.38% vs 6.41% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 78.38% vs 19.35% in Dec 2024
About Dar Al Dawa Development & Investment Co. Ltd. 
Dar Al Dawa Development & Investment Co. Ltd.
Pharmaceuticals & Biotechnology
Dar Al Dawa Development and Investment Company PSC is a Jordan-based pharmaceutical company, which is engaged in the manufacturing of pharmaceutical and consumer health products. The Company’s main activities are producing medical, chemical and pharmaceutical products, and importing pharmaceutical products. The Company operates an integrated network of 11 manufacturing facilities spread across Jordan, Middle East and North Africa region, as well as Romania. Its Pharmaceutical Development Unit focuses on the process developing of various dosage forms including tablets, capsules, liquids, dry suspensions, suppositories, creams, ointments, gels, parenterals, ophthalmic and nasal preparations. The Analytical Research unit engages in the analytical method development, validation, physiochemical characterization and stability studies.
Company Coordinates 
Company Details
Dar Al Dawa Dvlpmnt & Instmnt Co Bldg, Wadi Saqrah Street, Al Rabia Area, P.O.Box 9364, AMMAN None : 11191
Registrar Details






